Skip Navigation
Skip to contents



12 results

Efficacy of Pre- and Postoperative Chemotherapy in Patients with Osteosarcoma of the Extremities

Sohn JH, Rha SY, Jeung HC, Shin HJ, Goo YS, Chung HC, Yang WI, Hahn SB, Shin KH, Min JS, Kim BS, Roh JK, Jang WI

  • Cancer Res Treat.
  • 2001 Dec;33(6):520-526.
PURPOSE: We evaluated the treatment efficacy including survival and recurrence, and factors associated with recurrence in osteosarcoma patients treated with preoperative chemotherapy, surgery, and adjuvant chemotherapy. MATERIALS AND METHODS: Forty nine...
Proportion of Death Certificate Only Cases and Its Related Factors, Kwangju Cancer Registry (KCR)

Lee SJ, Shin MH, Kim SY, Park KS, Kim YJ, Hwang TJ, Choi JS

  • Cancer Res Treat.
  • 2001 Dec;33(6):512-519.
PURPOSE: To ascertain the factors associated with the proportion of death certificate only (DCO) cases contained in the Kwangju Cancer Registry (KCR) that are not as yet in the good...
Evaluation of E1B-mutant Replicating Adenoviruses for Cancer Gene Therapy

Kim JS, Kim JH, Lee HR, Jung KC, Yun CO

  • Cancer Res Treat.
  • 2001 Dec;33(6):500-511.
PURPOSE: Gene-attenuated replication-competent adenoviruses are emerging as a promising new modality for the treatment of cancer. In an effort to continually improve upon cancer gene therapy, we have modified gene-...
Mutation of Ha-ras Oncogene in Rat Salivary Gland Tumors Induced by DMBA

Yeh BI, Han DP, Sohn JH, Yoon JH, Lee HA, Chang SJ, Kong ID, Kim HW, Choi JW

  • Cancer Res Treat.
  • 2001 Dec;33(6):495-499.
PURPOSE: The incidence of salivary gland tumor is approximately 2% among all head and neck tumors, of which malignant cases account for only about 5%. Much research has been performed...
Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locoregional Esophageal Cancer

Lee GW, Kang JH, Kim HG, Hwang IG, Shim KS, Kim SH, Lee WS, Jung WT, Lee OJ, Cho JH, Jang JS, Chae KY, Lee JS

  • Cancer Res Treat.
  • 2001 Dec;33(6):489-494.
PURPOSE: The object of this study is to evaluate the efficacy and toxicity of induction chemotherapy followed by concomitant chemoradiotherapy in locoregional esophageal cancer. MATERIALS AND METHODS: Between December 1992 and...
Clinical Significance of Peripheral Blood CEA mRNA Expression in Gastric Cancer Patients Underwent Curative Resection

Seo JH, Park SH, Bak CW, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS, Mok YJ, Kim JS, Han SA, Yoon JI

  • Cancer Res Treat.
  • 2001 Dec;33(6):483-488.
PURPOSE: Recent advances in molecular technology have made it possible to detect small numbers of circulating tumor cells in the peripheral blood or bone marrow. Carcinoembryonic antigen (CEA) is an...
Reoperation of Recurrent Gastric Cancer

Park SM, Lee CH, Park CH, Kim W, Ahn CJ, Lim GW, Park WB, Kim SN, Kim IC

  • Cancer Res Treat.
  • 2001 Dec;33(6):478-482.
PURPOSE: The aim of this study was to evaluate the outcome of reoperation in recurrent gastric cancers. MATERIALS AND METHODS: We conducted a retrospective analysis of 86 patients who underwent reoperation...
Clinical Features of Neuroendocrine Lung Cancer

Kim EK, Jang GD, Suh CW, Kim SW, Lee SD, Kim WS, Lee JS, Lee HJ, Lee IC

  • Cancer Res Treat.
  • 2001 Dec;33(6):474-477.
PURPOSE: This study was performed to investigate the clinical features of neuroendocrine lung cancer. MATERIALS AND METHODS: We performed a retrospective review of the histopathology and clinical information of 21 patients...
Efficacy of Low-dose Paclitaxel and Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer

Kim BS, Oh DY, Joh YH, Kim DY, Kim JH, Lee SH, Lee DH, Kim TY, Heo DS, Bang YJ, Kim NK

  • Cancer Res Treat.
  • 2001 Dec;33(6):469-473.
PURPOSE: To evaluate the efficacy and toxicity of combination chemotherapy with low-dose paclitaxel and cisplatin in patients with advanced non-small cell lung cancer. MATERIALS AND METHODS: Chemotherapy-naive patients with unresectable, pathologically...
Sarcoma and Sarcomatous Metaplastic Carcinoma of the Breast

Yu SH, Noh WC, Bang HY, Hwang DY, Choi DW, Lee JI, Paik NS, Moon NM, Jung JH

  • Cancer Res Treat.
  • 2001 Dec;33(6):463-468.
PURPOSE: Primary sarcoma and SMC (sarcomatous metaplastic carcinoma) of the breast are very rare tumors, accounting for less than 1% of all breast malignancies. There are many controversies concerning the...
Clinical Analysis of Phyllodes Tumor of the Breast

Han SH, Lee WG, Cha KH, Lee TH, Shin DB, Ha SY, Park HG

  • Cancer Res Treat.
  • 2001 Dec;33(6):458-462.
PURPOSE: Phyllodes tumors are fibroepithelial mammary lesions that tend to behave in a benign fashion but may undergo sarcomatous transformation. They account for 0.3 to 0.5 percent of all breast...
A Phase II Study of Genexol(R) (paclitaxel) in Metastatic Breast Cancer

Jung JY, Jeong HC, Yoon SS, Lee JH, Kim JS, Kim HJ, Kim KH, Park JO, Lee WS, Heo DS, Bang YJ, Kim NK

  • Cancer Res Treat.
  • 2001 Dec;33(6):451-457.
PURPOSE: Paclitaxel is a very effective agent in the treatment of breast cancer. Samyang Corporation has developed its own process to produce paclitaxel in a large volume using plant cell...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: